Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
15,469
Total Claims
$1.2M
Drug Cost
584
Beneficiaries
$2,012
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-95%
Opioid rate vs peers
0.1% vs 2.2% avg
+43%
Cost per patient vs peers
$2,012 vs $1,411 avg
+73%
Brand preference vs peers
18.4% vs 10.6% avg
Opioid Prescribing
0.1%
Opioid Rate
19
Opioid Claims
$657
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,841 claims · $856K
Generic: 12,592 claims · $319K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 671 | $185K |
| Collagenase Clostridium Hist. | 37 | $154K |
| Bictegrav/Emtricit/Tenofov Ala | 13 | $52K |
| Dulaglutide | 100 | $45K |
| Insulin Glargine,hum.Rec.Anlog | 317 | $37K |
| Dolutegravir Sodium | 21 | $35K |
| Insulin Aspart | 167 | $25K |
| Empagliflozin | 71 | $20K |
| Tiotropium Bromide | 41 | $19K |
| Liraglutide | 39 | $17K |
| Rivaroxaban | 62 | $16K |
| Potassium Chloride | 287 | $13K |
| Insulin Glargine,hum.Rec.Anlog | 121 | $12K |
| Lipase/Protease/Amylase | 28 | $12K |
| Sitagliptin Phosphate | 41 | $11K |
Prescribing Profile
Patient Profile
74
Avg Age
52%
Female
3.09
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About